Table 3.
Quartiles of baseline angiopoietin-2 and von Willebrand factor and ventilator-free days in patients with acute lung injury
Baseline Biomarker Level | Mean Change in Ventilator-Free Days (95% Confidence Interval) | p |
---|---|---|
Angiopoietin-2 (infection-related acute lung injury) | ||
First quartile | Referent | N/A |
Second quartile | −2.2 (−4.6 to 0.16) | .07 |
Third quartile | −2.5 (−4.8 to −0.1) | .04 |
Fourth quartile | −4.1 (−6.3 to −1.8) | <.001 |
Test for trend across quartiles | — | .006 |
| ||
Angiopoietin-2 (noninfection-related acute lung injury) | ||
First quartile | Referent | N/A |
Second quartile | −2.4 (−5.4 to 0.7) | .13 |
Third quartile | −7.1 (−10.3 to −3.9) | <.001 |
Fourth quartile | −5.7 (−9.6 to −1.8) | .004 |
Test for trend across quartiles | — | .0001 |
| ||
von Willebrand factor | ||
First quartile | Referent | N/A |
Second quartile | −0.5 (−2.4 to 1.4) | .59 |
Third quartile | −1.9 (−3.8 to −0.03) | .046 |
Fourth quartile | −4.6 (−6.5 to −2.7) | <.001 |
Test for trend across quartiles | — | <.0001 |
N/A, not applicable.